Compare $IMUC vs $VTGN | Chartloom

Compare

$IMUC vs $VTGN

Eom Pharmaceutical Holdings Inc · Vistagen Therapeutics Inc

IMUC

Eom Pharmaceutical Holdings Inc

VTGN

Vistagen Therapeutics Inc

Compare $IMUC vs $VTGN

Comparing Eom Pharmaceutical Holdings Inc and Vistagen Therapeutics Inc

IMUCEom Pharmaceutical Holdings Inc

VTGNVistagen Therapeutics Inc

IMUCEom Pharmaceutical Holdings Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-51.3%

52W performance

-31.7%

FCF yield

-18.9%

VTGNVistagen Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

278.5%

YTD performance

-65.2%

52W performance

-94.1%

FCF yield

-644.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMUC

VTGN

Detailed metrics comparison

IMUC

Eom Pharmaceutical Holdings Inc

VTGN

Vistagen Therapeutics Inc

Market Cap

IMUC$12M

VTGN$10M

Enterprise Value

IMUC$14M

VTGN$-7M

Price

IMUC$0.10

VTGN$0.24

P/E Ratio

IMUCN/A

VTGNN/A

P/S Ratio

IMUC0.00x

VTGN3.87x

EV/Sales

IMUC0.00x

VTGN-2.92x

EV/EBITDA

IMUC0.00x

VTGN0.00x

P/B Ratio

IMUC3.51x

VTGN0.56x

P/FCF Ratio

IMUCN/A

VTGNN/A

EV/FCF

IMUC-6.11x

VTGN0.12x

PEG Ratio

IMUCN/A

VTGNN/A

Forward P/E (NTM)

IMUCN/A

VTGNN/A

Forward P/S (NTM)

IMUCN/A

VTGNN/A

Revenue (TTM)

IMUC$0

VTGN$3M

Revenue Growth (YoY)

IMUCN/A

VTGN278.5%

Forward Rev Growth

IMUC0.0%

VTGN4633.2%

Gross Margin (TTM)

IMUC0.0%

VTGN0.0%

Operating Margin (TTM)

IMUC0.0%

VTGN0.0%

EBITDA Margin (TTM)

IMUC0.0%

VTGN-2775.9%

Net Margin (TTM)

IMUC0.0%

VTGN-2702.6%

FCF Margin (TTM)

IMUCN/A

VTGN-2493.3%

Net Income (TTM)

IMUC$-6M

VTGN$-68M

FCF (TTM)

IMUC$-2M

VTGN$-62M

EPS (TTM)

IMUC-$0.05

VTGN-$1.57

ROE (TTM)

IMUC-4502.0%

VTGN-15259.0%

ROA (TTM)

IMUC-45737.0%

VTGN-11745.0%

ROIC (TTM)

IMUC-4502.0%

VTGN-15162.0%

Cash

IMUC$933K

VTGN$17M

Debt

IMUC$3M

VTGN$0

Net Cash/Debt

IMUC$-2M

VTGN$17M

Current Ratio (TTM)

IMUC1.51x

VTGN3.07x

Quick Ratio (TTM)

IMUC1.28x

VTGN2.84x

Debt/Equity (TTM)

IMUC0.00x

VTGN0.00x

Debt/Assets (TTM)

IMUC0.0%

VTGN0.0%

Interest Coverage (TTM)

IMUCN/A

VTGNN/A

Net Debt/EBITDA (TTM)

IMUC0.00x

VTGN0.00x

Beta

IMUC0.80

VTGN0.49

52W Performance

IMUC-31.7%

VTGN-94.1%

YTD Performance

IMUC-51.3%

VTGN-65.2%

% from 52W High

IMUC-72.1%

VTGN-95.4%

% from 52W Low

IMUC375.0%

VTGN19.2%

Asset Turnover (TTM)

IMUC0.00x

VTGN0.04x

FCF Yield (TTM)

IMUC-18.9%

VTGN-644.0%

Earnings Yield (TTM)

IMUC-49.4%

VTGN-698.0%

Dividend Yield (TTM)

IMUCN/A

VTGNN/A

Rule of 40

IMUC0.0

VTGN-2,214.8

EV/GP/RG

IMUCN/A

VTGNN/A

Ticker research

View IMUC research View VTGN research

Metric	IMUC Eom Pharmaceutical Holdings Inc	VTGN Vistagen Therapeutics Inc
Market & Valuation
Market Cap	$12M	$10M
Enterprise Value	$14M	$-7M
Price	$0.10	$0.24
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.87x
EV/Sales	0.00x	-2.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.51x	0.56x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.11x	0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	278.5%
Forward Rev Growth	0.0%	4633.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2775.9%
Net Margin (TTM)	0.0%	-2702.6%
FCF Margin (TTM)	N/A	-2493.3%
Net Income (TTM)	$-6M	$-68M
FCF (TTM)	$-2M	$-62M
EPS (TTM)	-$0.05	-$1.57
ROE (TTM)	-4502.0%	-15259.0%
ROA (TTM)	-45737.0%	-11745.0%
ROIC (TTM)	-4502.0%	-15162.0%
Financial Health
Cash	$933K	$17M
Debt	$3M	$0
Net Cash/Debt	$-2M	$17M
Current Ratio (TTM)	1.51x	3.07x
Quick Ratio (TTM)	1.28x	2.84x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.80	0.49
52W Performance	-31.7%	-94.1%
YTD Performance	-51.3%	-65.2%
% from 52W High	-72.1%	-95.4%
% from 52W Low	375.0%	19.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-18.9%	-644.0%
Earnings Yield (TTM)	-49.4%	-698.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,214.8
EV/GP/RG	N/A	N/A
Ticker research	View IMUC research	View VTGN research

Valuation

P/S Ratio

IMUC

0.00x

VTGN

3.87x

EV/FCF

IMUC

-6.11x

VTGN

0.12x

Growth & revenue

Revenue Growth TTM

VTGN

278.5%

Forward Revenue Growth

VTGN

4633.2%

IMUC

0.0%

Profitability & performance

Gross Margin

IMUC

0.0%

VTGN

0.0%

ROE

IMUC

-4502.0%

VTGN

-15259.0%

FCF Yield %

IMUC

-18.9%

VTGN

-644.0%

52-Week Performance

IMUC

-31.7%

VTGN

-94.1%

Detailed metrics comparison

IMUC

Eom Pharmaceutical Holdings Inc

VTGN

Vistagen Therapeutics Inc

Market Cap

IMUC$12M

VTGN$10M

Enterprise Value

IMUC$14M

VTGN$-7M

Price

IMUC$0.10

VTGN$0.24

P/E Ratio

IMUCN/A

VTGNN/A

P/S Ratio

IMUC0.00x

VTGN3.87x

EV/Sales

IMUC0.00x

VTGN-2.92x

EV/EBITDA

IMUC0.00x

VTGN0.00x

P/B Ratio

IMUC3.51x

VTGN0.56x

P/FCF Ratio

IMUCN/A

VTGNN/A

EV/FCF

IMUC-6.11x

VTGN0.12x

PEG Ratio

IMUCN/A

VTGNN/A

Forward P/E (NTM)

IMUCN/A

VTGNN/A

Forward P/S (NTM)

IMUCN/A

VTGNN/A

Revenue (TTM)

IMUC$0

VTGN$3M

Revenue Growth (YoY)

IMUCN/A

VTGN278.5%

Forward Rev Growth

IMUC0.0%

VTGN4633.2%

Gross Margin (TTM)

IMUC0.0%

VTGN0.0%

Operating Margin (TTM)

IMUC0.0%

VTGN0.0%

EBITDA Margin (TTM)

IMUC0.0%

VTGN-2775.9%

Net Margin (TTM)

IMUC0.0%

VTGN-2702.6%

FCF Margin (TTM)

IMUCN/A

VTGN-2493.3%

Net Income (TTM)

IMUC$-6M

VTGN$-68M

FCF (TTM)

IMUC$-2M

VTGN$-62M

EPS (TTM)

IMUC-$0.05

VTGN-$1.57

ROE (TTM)

IMUC-4502.0%

VTGN-15259.0%

ROA (TTM)

IMUC-45737.0%

VTGN-11745.0%

ROIC (TTM)

IMUC-4502.0%

VTGN-15162.0%

Cash

IMUC$933K

VTGN$17M

Debt

IMUC$3M

VTGN$0

Net Cash/Debt

IMUC$-2M

VTGN$17M

Current Ratio (TTM)

IMUC1.51x

VTGN3.07x

Quick Ratio (TTM)

IMUC1.28x

VTGN2.84x

Debt/Equity (TTM)

IMUC0.00x

VTGN0.00x

Debt/Assets (TTM)

IMUC0.0%

VTGN0.0%

Interest Coverage (TTM)

IMUCN/A

VTGNN/A

Net Debt/EBITDA (TTM)

IMUC0.00x

VTGN0.00x

Beta

IMUC0.80

VTGN0.49

52W Performance

IMUC-31.7%

VTGN-94.1%

YTD Performance

IMUC-51.3%

VTGN-65.2%

% from 52W High

IMUC-72.1%

VTGN-95.4%

% from 52W Low

IMUC375.0%

VTGN19.2%

Asset Turnover (TTM)

IMUC0.00x

VTGN0.04x

FCF Yield (TTM)

IMUC-18.9%

VTGN-644.0%

Earnings Yield (TTM)

IMUC-49.4%

VTGN-698.0%

Dividend Yield (TTM)

IMUCN/A

VTGNN/A

Rule of 40

IMUC0.0

VTGN-2,214.8

EV/GP/RG

IMUCN/A

VTGNN/A

Ticker research

View IMUC research View VTGN research

Metric	IMUC Eom Pharmaceutical Holdings Inc	VTGN Vistagen Therapeutics Inc
Market & Valuation
Market Cap	$12M	$10M
Enterprise Value	$14M	$-7M
Price	$0.10	$0.24
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.87x
EV/Sales	0.00x	-2.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.51x	0.56x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.11x	0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	278.5%
Forward Rev Growth	0.0%	4633.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2775.9%
Net Margin (TTM)	0.0%	-2702.6%
FCF Margin (TTM)	N/A	-2493.3%
Net Income (TTM)	$-6M	$-68M
FCF (TTM)	$-2M	$-62M
EPS (TTM)	-$0.05	-$1.57
ROE (TTM)	-4502.0%	-15259.0%
ROA (TTM)	-45737.0%	-11745.0%
ROIC (TTM)	-4502.0%	-15162.0%
Financial Health
Cash	$933K	$17M
Debt	$3M	$0
Net Cash/Debt	$-2M	$17M
Current Ratio (TTM)	1.51x	3.07x
Quick Ratio (TTM)	1.28x	2.84x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.80	0.49
52W Performance	-31.7%	-94.1%
YTD Performance	-51.3%	-65.2%
% from 52W High	-72.1%	-95.4%
% from 52W Low	375.0%	19.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-18.9%	-644.0%
Earnings Yield (TTM)	-49.4%	-698.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,214.8
EV/GP/RG	N/A	N/A
Ticker research	View IMUC research	View VTGN research